Experimental and Clinical Trials of New99mTc-Labeled Hepatobiliary Agents

Authors:
  • BWBrian W. Wistow
    Brian W. Wistow
  • GSGopal Subramanian
    Gopal Subramanian
  • GGGeorge M. Gagne
    George M. Gagne
  • RHRobert W. Henderson
    Robert W. Henderson
  • JMJohn G. McAfee
    John G. McAfee
  • RHRobert C. Hall
    Robert C. Hall
  • ZGZachary D. Grossman
    Zachary D. Grossman

Abstract
Several new derivatives of lidocaine were synthesized and used to examine the intra- and extrahepatic bile ducts and gallbladder. Diisopropyl-IDA exhibited approximately twice the bile concentration of 131I-rose bengal during the first hour after injection. P-butyl-IDA also concentrates moderately well in the bile and has the added advantage of very low excretion into the urine (2%). It seems more effective than the other IDA derivatives at high bilirubin levels.